Thanks to Zachary Klaassen for a great conversation on BCG unresponsive non-muscle invasive #bladdercancer —working through three common, real-world patient cases to think through practical considerations on sequencing and using these new therapies.
www.urotoday.com/video-lectur...
urotoday.com
Nadofaragene Firadenovec for BCG-Unresponsive CIS: Efficacy, Durability, and Practical Considerations - Vikram Narayan
Zachary Klaassen speaks with Vikram Narayan from Emory University about nadofaragene firadenovec, a first-in-class gene therapy for BCG-unresponsive bladder cancer. Dr. Narayan explains how this non-r...
